One Man's last hope: experimental Light-Activated cancer therapy
NCT ID NCT06836648
Summary
This is a single-patient, compassionate-use trial for a man with advanced prostate cancer who has run out of standard treatment options. The study is testing a new approach called X-PACT, which involves injecting a plant-derived drug directly into the tumor and then activating it with X-rays. The goal is to kill the local tumor and potentially trigger the patient's own immune system to fight the cancer elsewhere in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kimmel Cancer Center at Johns Hopkins at Sibley Memorial Hospital
AVAILABLEWashington D.C., District of Columbia, 20016, United States
Conditions
Explore the condition pages connected to this study.